What is Viridian Therapeutics, Inc.'s capex?

Viridian Therapeutics, Inc. (VRDN) reported capex of $23K in Q1 2026.

How has Viridian Therapeutics, Inc.'s capex changed year-over-year?

Viridian Therapeutics, Inc.'s capex decreased by 73.3% year-over-year, from $86K to $23K.

What is the long-term trend for Viridian Therapeutics, Inc.'s capex?

Over 4 years (2021 to 2025), Viridian Therapeutics, Inc.'s capex has grown at a 10.0% compound annual growth rate (CAGR), from $338K to $495K.

What does capex mean?

Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

Viridian Therapeutics, Inc. VRDN CapEx

CapEx at other companies

AmgenAMGN

$712M+73.2%

Immunovant, Inc.IMVT

$8K-96.0%

ANI PharmaceuticalsANIP

$6.07M+146%

Vir Biotechnology, Inc.VIR

$390K-76.1%

Nektar TherapeuticsNKTR

$18K+800%

Vera TherapeuticsVERA

$23K-87.7%

Other financials

Income statement

See full

Revenue$141.0K+95.8%

Operating income-$116.2M-23.8%

Net income-$104.9M-20.7%

EPS (diluted)-$1.15-5.5%

Balance sheet

See full

Cash & equivalents$176.3M+51.7%

Total debt$36.8M+59.4%

Total equity$636.0M+5.2%

Total assets$789.0M+19.4%

Cash flow

See full

Operating cash flow-$119.7M-29.1%

Free cash flow-$119.7M-29.0%

Valuation

See full

Market cap$1.91B+82.0%

Enterprise value$1.77B+85.0%

P/S26.9×-3,445×

Profitability

See full

Gross margin36.3%—

Operating margin-543.9%-271pp

Net margin-508.5%-254pp

FCF margin-428.4%-214pp

Returns & leverage

See full

Return on equity-58.1%+7.9pp

Debt / equity0.1×0.0×

Current ratio15.1×-4.3×

Where this comes from

Reported directly by Viridian Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Viridian Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viridian Therapeutics, Inc.'s capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Viridian Therapeutics, Inc.'s capex?: Viridian Therapeutics, Inc. (VRDN) reported capex of $23K in Q1 2026.
How has Viridian Therapeutics, Inc.'s capex changed year-over-year?: Viridian Therapeutics, Inc.'s capex decreased by 73.3% year-over-year, from $86K to $23K.
What is the long-term trend for Viridian Therapeutics, Inc.'s capex?: Over 4 years (2021 to 2025), Viridian Therapeutics, Inc.'s capex has grown at a 10.0% compound annual growth rate (CAGR), from $338K to $495K.
What does capex mean?: Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.